Mimedx Group Inc

-0.29 (-2.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.26B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$59.9 Million
Adjusted EPS-$0.19
See more estimates
10-Day MA$11.76
50-Day MA$10.39
200-Day MA$7.23
See more pivots

MiMedx Group, Inc. Stock, NASDAQ:MDXG

1775 West Oak Commons Court NE, 1775 West Oak Commons Court NE, Marietta, Georgia 30062
United States of America
Phone: +1.770.651.9100
Number of Employees: 696


MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.